Endo International | Salg Og Administrasjonskostnader

Selling And Administration Expenses Endring Dato
Amarin USD 45.46M 5.5M 2023-09
ANI Pharmaceuticals USD 44.46M 2.46M 2023-12
Eli Lilly USD 1.92B 120.7M 2023-12
Hikma Pharmaceutical USD 260M 7M 2023-06
Ligand Pharmaceuticals USD 15.99M 1.34M 2023-12
Pacira USD 65.8M 2.15M 2023-12
Perrigo USD 304M 28.3M 2023-09
Pfizer USD 4.47B 1.27B 2023-12
Supernus Pharmaceuticals USD 81.28M 1.42M 2023-12
Takeda JPY 252.95B 4.84B 2023-09
Teva Pharmaceutical Industries USD 844M 66M 2023-09
Xeris Pharmaceuticals USD 37.29M 348K 2023-09
Zoetis USD 565M 40M 2023-12



Endo International Salg Og Administrasjonskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.